221 related articles for article (PubMed ID: 19628872)
1. PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.
Selvaraj V; Soundarapandian MM; Chechneva O; Williams AJ; Sidorov MK; Soulika AM; Pleasure DE; Deng W
J Biol Chem; 2009 Sep; 284(38):26070-84. PubMed ID: 19628872
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of phospholipase D1 in the spinal cords of rats with experimental autoimmune encephalomyelitis.
Ahn M; Min DS; Kang J; Jung K; Shin T
Neurosci Lett; 2001 Dec; 316(2):95-8. PubMed ID: 11742724
[TBL] [Abstract][Full Text] [Related]
3. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis.
Kamboj A; Lu P; Cossoy MB; Stobart JL; Dolhun BA; Kauppinen TM; de Murcia G; Anderson CM
J Neuroinflammation; 2013 Apr; 10():49. PubMed ID: 23607899
[TBL] [Abstract][Full Text] [Related]
5. PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.
Cavone L; Aldinucci A; Ballerini C; Biagioli T; Moroni F; Chiarugi A
Mult Scler; 2011 Jul; 17(7):794-807. PubMed ID: 21343230
[TBL] [Abstract][Full Text] [Related]
6. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice.
Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X
Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389
[TBL] [Abstract][Full Text] [Related]
8. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
9. Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.
Marusic S; Leach MW; Pelker JW; Azoitei ML; Uozumi N; Cui J; Shen MW; DeClercq CM; Miyashiro JS; Carito BA; Thakker P; Simmons DL; Leonard JP; Shimizu T; Clark JD
J Exp Med; 2005 Sep; 202(6):841-51. PubMed ID: 16172261
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
11. Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Miyamoto K; Tanaka N; Moriguchi K; Ueno R; Kadomatsu K; Kitagawa H; Kusunoki S
Glycobiology; 2014 May; 24(5):469-75. PubMed ID: 24584141
[TBL] [Abstract][Full Text] [Related]
12. Epithelial V-like antigen mediates efficacy of anti-alpha₄ integrin treatment in a mouse model of multiple sclerosis.
Wright E; Rahgozar K; Hallworth N; Lanker S; Carrithers MD
PLoS One; 2013; 8(8):e70954. PubMed ID: 23951051
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
[TBL] [Abstract][Full Text] [Related]
14. Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
Lévesque SA; Paré A; Mailhot B; Bellver-Landete V; Kébir H; Lécuyer MA; Alvarez JI; Prat A; de Rivero Vaccari JP; Keane RW; Lacroix S
J Exp Med; 2016 May; 213(6):929-49. PubMed ID: 27139491
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses.
Gris D; Ye Z; Iocca HA; Wen H; Craven RR; Gris P; Huang M; Schneider M; Miller SD; Ting JP
J Immunol; 2010 Jul; 185(2):974-81. PubMed ID: 20574004
[TBL] [Abstract][Full Text] [Related]
16. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
[TBL] [Abstract][Full Text] [Related]
17. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
18. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
19. GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
Orsini H; Araujo LP; Maricato JT; Guereschi MG; Mariano M; Castilho BA; Basso AS
Brain Behav Immun; 2014 Mar; 37():177-86. PubMed ID: 24362236
[TBL] [Abstract][Full Text] [Related]
20. A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.
Mills JH; Kim DG; Krenz A; Chen JF; Bynoe MS
J Immunol; 2012 Jun; 188(11):5713-22. PubMed ID: 22529293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
